Update in ARDS management: Recent randomized controlled trials that changed our practice

J. Fernando Santacruz, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

Enrique Diaz Guzman Zavala, MD
Division of Internal Medicine, The Cleveland Clinic Foundation

Alejandro C. Arroliga, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Head, Section of Critical Care Medicine, Department of Pulmonary, Allergy, and Critical Care, The Cleveland Clinic Foundation

Address: Alejandro C. Arroliga, MD, Intensive Care Unit, G6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail arrolia@ccf.org

J. Fernando Santacruz, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

Enrique Diaz Guzman Zavala, MD
Division of Internal Medicine, The Cleveland Clinic Foundation

Alejandro C. Arroliga, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Head, Section of Critical Care Medicine, Department of Pulmonary, Allergy, and Critical Care, The Cleveland Clinic Foundation

Address: Alejandro C. Arroliga, MD, Intensive Care Unit, G6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail arrolia@ccf.org

J. Fernando Santacruz, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

Enrique Diaz Guzman Zavala, MD
Division of Internal Medicine, The Cleveland Clinic Foundation

Alejandro C. Arroliga, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Head, Section of Critical Care Medicine, Department of Pulmonary, Allergy, and Critical Care, The Cleveland Clinic Foundation

Address: Alejandro C. Arroliga, MD, Intensive Care Unit, G6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail arrolia@ccf.org